Tuesday, December 22, 2009

Protein Could Yield Treatments For Liver Cancer

A protein switch called TAK1 helps prevent liver damage, including inflammation, fibrosis and cancer.

Research from United States and Japanese scientists explain that learning more about how TAK1 works could improve understanding about the development of liver disease and cancer, and lead to new therapies.

The researchers noted these findings in their report, released online in advance of publication in an upcoming print issue of the Proceedings of the National Academy of Sciences.

TAK1 appears to be a master regulator of liver function according to the dean of the University of California San Diego School of Medicine statement issued in a university news release.

It was already known that TAK1 activates two proteins that play a role in immunity, inflammation, programmed cell death and cancer. But it wasn't clear whether TAK1 promotes or prevents liver cancer.
To investigate this question, scientists created mice with liver cells that lacked TAK1 and found that the mice had a high rate of liver cell death. To compensate, the rodents' livers produced too many cells, resulting in liver damage that led to liver cancer, the researchers found.

Posted by the American Association for Critical Illness Insurance. Visit our website for more information on critical illnesses and a form of insurance that pays a tax-free lump sum payment upon diagnosis of cancer.

Saturday, December 19, 2009

Calorie Intake Linked To Longevity And Cancer Development

Cutting consumption of glucose, the most common dietary sugar, can extend the life of healthy human cells and speed the death of precancerous cells, reducing cancer's spread and growth rate.

According to findings reported by researchers from the University of Alabama at Birmingham, reducing calorie-intake can benefit longevity and help prevent diseases like cancer that have been linked to aging.

The researchers conducted tests by growing both healthy human-lung cells and precancerous human-lung cells in laboratory flasks. The flasks were provided either normal levels of glucose or significantly reduced amounts of the sugar compound, and the cells then were allowed to grow for a period of weeks. Restricted glucose levels led the healthy cells to grow longer than is typical and caused the precancerous cells to die off in large numbers.

Every year some 1.4 million Americans are diagnosed with cancer. It ranks as one of the leading factors for the need for costly long-term care according to the American Association for Critical Illness Insurance among aging seniors.

Two key genes were affected in the cellular response to decreased glucose consumption. The first gene, telomerase, encodes an important enzyme that allows cells to divide indefinitely. The second gene, p16, encodes a well known anti-cancer protein.

Healthy cells saw their telomerase rise and p16 decrease, which would explain the boost in healthy cell growth, the researchers explained. The research into the links between calorie intake, aging and the onset of diseases related to aging is thought to be a first of its kind given that it used the unique approach of testing human cells versus laboratory animals.

Monday, December 14, 2009

Many Stroke Survivors Don't Take Lifesaving Meds

About one-fifth of ischemic stroke survivors don't take medications that can reduce their risk of another stroke.

According to research, about 19 percent of patients didn't take prescribed blood thinners. Each year about 600,000 Americans experience their first stroke and 185,000 have a recurrent stroke according to the American Association for Critical Illness Insurance.

Stroke is the third leading cause of death in the United States. Over 143,579 people die each year from stroke in the United States and stroke is a leading cause of serious long-term disability. Nearly three-quarters of all strokes occur in people over the age of 65. The risk of having a stroke more than doubles each decade after the age of 55 the Association notes.

Ischemic stroke is caused by blocked blood flow in the brain. Several types of medications can reduce the risk of another ischemic stroke. These include blood thinners - also known as antithrombotic medications, of which aspirin is the most common.

This seven-year study conducted by the University of California, Los Angeles, examined 4,168 ischemic stroke survivors. Researchers found that about 19 percent of patients didn't take blood thinners. Men, older patients and non-Hispanic patients were more likely to take blood thinners.

The study will be published in the January issue of the American Journal of Preventive Medicine.

Tuesday, December 8, 2009

Drinking Coffee Reduces Risk of Advanced Prostate Cancer

A new study reveals a strong inverse association between coffee consumption and the risk of lethal and advanced prostate cancers.

Data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference revealed that coffee has effects on insulin and glucose metabolism as well as sex hormone levels, all of which play a role in prostate cancer.

Medical researchers report that that men who drank the most coffee had a 60 percent lower risk of aggressive prostate cancer than men who did not drink any coffee. This is the first study of its kind to look at both overall risk of prostate cancer and risk of localized, advanced and lethal disease.

Some 745,000 men are diagnosed with cancer each year in the United States according to the American Association for Critical Illness Insurance that tracks critical illness data for cancers, heart attack and stroke. Approximately 300,000 men die each year of cancer.

The researchers are unsure which components of the beverage are most important, as coffee contains many biologically active compounds like antioxidants and minerals. They study examined both regular and decaffeinated coffee intake of nearly 50,000 men every four years from 1986 to 2006.

Nearly 5,000 men developed prostate cancer over that time. The researchers examined the association between coffee consumption and levels of circulating hormones in blood samples collected from a subset of men in the cohort. The results do suggest there is no reason to stop drinking coffee out of any concern about prostate cancer, the report adds.

For free price quote for critical illness insurance, go to: American Association for Critical Illness Insurance Consumer information Center.

Saturday, December 5, 2009

Smoking Exposure Now Linked to Colon And Breast Cancers

Add colorectal and breast cancer to the list of malignancies caused by smoking according to new studies.

Two studies strengthen the case for the dangers of secondhand smoke for people exposed to fumes as children and as adults. According to the American Association for Critical Illness Insurance, some 17 cancers are now attributed to smoking. Cancer and heart disease are the major critical illnesses impacting millions of Americans yearly.

Inhaling secondhand fumes may raise a woman's odds for breast cancer or a child's lifetime risk for lung malignancies according to the studies. Another study found that long-term smokers have a higher risk of developing colorectal cancer, a finding that factored into the recent decision by the International Agency for Research on Cancer (IARC) to assert that there is "sufficient" evidence to link the two, up from its previous "limited" evidence.

In preparing their reports, the researchers adjusted for other colorectal cancer risk factors, such as not getting screened, obesity, physical activity and eating a lot of red or processed meats. They noted that people who smoke are already more likely to engage in these types of behaviors.

This study followed almost 200,000 people over 13 years. According to the medical researchers, current smokers had a 27 percent increased risk of colorectal cancer and former smokers a 23 percent increased risk compared with people who had never smoked.

People who had smoked for at least half a century had the highest risk -- 38 percent higher than never smokers -- of developing colorectal cancer. People who ceased smoking before the age of 40 or who had not smoked for 31 or more years had no increased risk.

Other studies focused on the risk of secondhand smoke, or passive smoking. In one, children exposed to secondhand smoke had a higher risk of developing lung cancer as adults, researchers from institutions including the U.S. National Cancer Institute found. In another, California researchers found that adult non-smoking women who had spent long periods of time in smoking environments upped their odds of developing postmenopausal breast cancer.

The breast cancer findings were seen mostly in postmenopausal women, with a 17 percent higher risk for those who had had low exposure, a 19 percent increased risk for those with medium exposure and a 26 percent increased risk for those who had high long-term exposure over their lifetime.

The studies were published in the December issue of Epidemiology, Biomarkers & Prevention,

Thursday, December 3, 2009

More Americans Surviving Lung Cancer

Survival rates for advanced lung cancer patients in the United States have improved modestly.

According to the new study, researchers found that one-year overall survival rate for lung cancer increased from 13.2 percent in 1990 to 19.4 percent in 2005, while two-year overall survival increased from 4.5 percent to 7.8 percent.

Some 1.4 million Americans are diagnosed with cancer according to the American Association for Critical Illness Insurance. Lung and bronchial cancers account for about 15 percent of all cancer.

Researchers analyzed data on more than 100,000 patients diagnosed with stage 4 non-small cell lung cancer (NSCLC) between 1990 and 2005. The patient information was in the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results database.

The study authors noted that the improved survival rates may come from changes in the management of advanced lung cancer over the past two decades, including new chemotherapy agents and regimens, increased use of salvage chemotherapy and the introduction of molecularly targeted therapies.

The study is published in the December issue of the Journal of Thoracic Oncology.

Wednesday, December 2, 2009

First National Critical Illness Insurance Study Examines U.S. Buyers

Nearly half of individuals purchasing critical illness insurance protection were under age 45 according to the first national study of buyers conducted by the American Association for Critical Illness Insurance.

The industry trade group released the findings of a study that reveals one third (34%) of purchasers were between ages 45 and 54 and the majority (87%) purchased $50,000 or less in benefits. The study examined sales data for over 130,000 individual and voluntary worksite policies and certificates issued.

"Critical illness insurance is growing in acceptance as consumers understand the risk and financial exposure resulting from cancer, a heart attack or stroke," explains Jesse Slome, the organization's executive director. First introduced in the United States in 1996, some 600,000 individuals have purchased critical illness coverage available from about 20 insurance companies.

Nearly a quarter (24%) of individual buyers opted for coverage of less than $20,000 according to the study's findings. For those purchasing in the worksite setting, some 65 percent chose benefits of $20,000 or less.

The vast majority of purchasers do so prior to turning age 55. Among those purchasing individual critical illness insurance policies, 20 percent were under age 35; 27 percent were between ages 35 and 44 and 34 percent were between 45 and 54. Buyers purchasing coverage in the workplace were about the same age according to the Association report. Policies providing a $10,000 benefit for a 40 year old can range from $150 to $300-per-year.

Individual buyers tended to be male (52% versus 48% female) while those purchasing in the workplace were more likely to be female (59% versus 41% male).

"We anticipate the market for critical illness insurance products will increase in the years ahead," predicts Slome. The Los Angeles-based association will undertake an aggressive consumer awareness campaign in 2010 to build an understanding of the benefits of the protection that is popular outside of the United States. "Every year, millions of Americans are diagnosed with a critical illness and the vast majority survive," Slome explains. "The financial cost even for those with health insurance can be devastating and one of the leading reasons 1.5 million Americans declared bankruptcy even before the current economic crisis." Critical illness insurance policies range in cost based on the age, sex and use of tobacco products. A policy providing a $10,000 cash benefit can range from about $150 a year to $400 a year experts explain.

Access to the full study results can be viewed on the organization's website http://www.aacii.org.

Tuesday, December 1, 2009

Diabetes Cases To Double In United States By 2034

The number of people with diabetes in the United States is expected to double over the next 25 years.

The study published in the December issue of Diabetes Care predicts that by 2034 about 44.1 million people will have the disease, up from 23.7 million today. At the same time, the cost of treating people with diabetes will triple, rising from an estimated $113 billion in 2009 to $336 billion in 2034.

Researchers note that a key factor driving the soaring costs is the number of people living with diabetes for lengthy periods. Over time, the cost of caring for someone with diabetes tends to rise along with their risk for developing complications, such as end-stage renal disease, which requires costly dialysis according to the American Association for Critical Illness Insurance.

In making their estimates, researchers at the University of Chicago used data on people 24 to 85 years old who took part in the U.S. Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey and the National Health Interview Study.

Prior forecasts, including the ones currently used by the federal government's budget analysts, have underestimated the burden, the researchers noted. A 1991 study, for example, predicted that 11.6 million people would have diabetes in 2030. In 2009, there were already more than twice that many living with diabetes.

Among Medicare beneficiaries, the number with diabetes is expected to rise from 8.2 million to 14.6 million in 2034, with an accompanying rise in spending from $45 billion to $171 billion the study reveals. The high cost of chronic disease is one of the most pressing issues facing the United States as legislators grapple with financial strains on Medicare and the larger issue of health-care reform, the researchers explained.

Factors driving the increase in diabetes cases include the aging population and continued high rates of obesity, both of which are risk factors for type 2 diabetes, in which the body does not produce enough insulin or the cells don't use it correctly. In the study, the researchers assumed that the obesity rate would remain relatively stable, topping out at about 30 percent in the next decade and then declining slightly to about 27 percent in 2033.

Monday, November 30, 2009

Ginkgo Won't Prevent Heart Attack Or Stroke in Elderly

The herbal supplement Ginkgo biloba does not prevent heart attacks, stroke or death when taken by people aged 75 and older.


Researchers report that the herbal supplement may help ward off peripheral artery disease. According to the findings of a new study, the popular herbal remedy might help prevent the leg-circulation problem known as peripheral artery disease.


Ginkgo contains nutrients called flavonoids, which are also found in fruits, vegetables, dark chocolate and red wine, and are believed to offer some protection against cardiovascular events, according to the researchers. The supplement, increasingly popular in the United States and Europe, has been touted to improve memory, and to prevent dementia, heart disease and stroke.


Researchers at the University of Pittsburgh found that ginkgo had no benefit in preventing heart attack or stroke. Consistent with observations of researchers in Europe, the medical experts noted that ginkgo appeared to have some benefit in preventing peripheral vascular disease.


Last year the same University of Pittsburgh team reported that ginkgo biloba had no effect on preventing dementia. For their latest study, researchers randomly assigned 3,069 patients to 120 milligrams of highly purified ginkgo biloba or placebo, twice a day as part of the Ginkgo Evaluation of Memory Study.


Over the six years of the trial, 385 participants died, 164 had heart attacks, 151 had strokes, 73 had mini-strokes ("transient ischemic attacks") and 207 had chest pain, the researchers found. There was no significant difference between those taking ginkgo or placebo for any of these outcomes, the study reports.


However, among the 35 people who were treated for peripheral artery disease, 23 received placebo and 12 were taking ginkgo -- a statistically significance difference, the researchers noted. About 8 million Americans have peripheral artery disease according to the American Association for Critical Illness Insurance.

Peripheral artery disease typically affects the arteries in the pelvis and legs. Symptoms include cramping and pain or tiredness in the hip muscles and legs when walking or climbing stairs, although not everyone who has PAD is symptomatic. The pain usually subsides during rest.


, , , ,

Tuesday, November 24, 2009

Vigorous Exercise Cuts Stroke Risk for Older Men, Not Women

Moderate-to-high intensity exercise may help reduce stroke risk in older men but not in women.

New research examined over 3,000 men and women, average age 69, who were followed for about nine years. During that time, there were 238 strokes among the participants. At the start of the study, 20 percent of the participants said they did regular moderate-to-high intensity exercise such as jogging, swimming or tennis.  Some 41 percent said they did no physical activity. 

Men who did moderate-to-high intensity exercise were 63 percent less likely to have a stroke than people who didn't exercise. Over five years, the baseline risk of ischemic stroke which is the leading type of stroke for all study participants was 4.3 percent; 2.7 percent for those who did moderate-to-high intensity exercise and 4.6 percent for those who didn't exercise.

The study conducted by researchers at Columbia University Medical Center and New York Presbyterian Hospital at Columbia appears in the Nov. 24 issue of the journal Neurology.  Taking part in moderate-to-heavy intensity physical activity may be an important factor for preventing stroke, noted the study's author. 

A large percentage of the participants were not taking part in any physical activities. This may be true of many elderly people who live in cities. Identifying ways to improve physical activity among these people may be a key goal for public health.

Stroke is the leading cause of disability in the United States and the third leading cause of death according to the American Association for Critical Illness Insurance, the national trade organization.  This year some 600,000 Americans will suffer their first stroke.

Monday, November 23, 2009

Kidney Transplant Plus Sleep Disorder Adds Up to Trouble

Kidney transplant patients with sleep apnea are at increased risk for high blood pressure, heart disease and stroke. 

Researchers in Hungary conducted a study of kidney transplant recipients and found that 25 percent had moderate to severe sleep apnea, a rate similar to that seen in kidney disease patients on dialysis awaiting a transplant. 

The findings they note indicate that both types of patients who have the breathing-related sleep disorder should be considered at high risk for serious heart-related complications.  Transplant recipients with sleep apnea were more than twice as likely as those without the syndrome to be taking three or more anti-hypertensive drugs, but still had higher blood pressure than those without the sleep disorder. Obesity increased a transplant patient's risk of developing sleep apnea. 

Organ transplants are increasingly available according to the American Association for Critical Illness Insurance.  Some critical illness policies will provide a cash benefit when a transplant is received.

When the Hungarian medical researchers calculated risk scores, they found that kidney disease patients with sleep apnea were twice as likely to suffer heart disease or stroke than those without sleep apnea.  They recommend that physicians should screen transplant patients for obstructive sleep apnea and offer appropriate treatment," the study authors concluded. 

The study will be published in January in the Clinical Journal of the American Society of Nephrology.

Saturday, November 21, 2009

Moderate Drinking May Help Your Heart

A Spanish study has found that long-term moderate drinking decreased the risk of heart disease by up to one-third in men and to a lesser degree in women.

The type of alcohol -- beer, wine or spirits -- made no difference, the researchers reported in the Nov. 19 online issue of Heart. The Spanish analysis used 10-year data on over 40,000 men and women who were participants in the European Prospective Investigation into Cancer study.

 But for men, there was a point at which the coronary benefits of alcohol declined, and risk began to rise again.  The rate of coronary heart disease for non-drinking women in the study was 56 per 100,000. For women listed as low drinkers, averaging less than 5 grams a day, it was 42. For women who were moderate drinkers (5 to 30 grams a day), it was 36; for high drinkers (30 to 90 grams a day) it was 12; and for heavy drinkers (more than 90 grams a day) it was 12.

The rates for men were 398 per 100,000 for those who never drank, 318 for low drinkers, 255 for moderate drinkers, 278 for high drinkers and 334 for heavy drinkers, the researchers reported.

The report showing that the source of alcohol made no difference does help puncture one explanation for what has come to be called the "French paradox," the low level of heart disease seen in that country despite consumption of what Americans would describe as an unhealthy, fat-rich diet. Some experts have attributed the paradox to the beneficial effects of red wine.

A number of well-done studies have shown that people who drink have higher levels of HDL cholesterol.  HDL cholesterol is the "good" kind that prevents formation of artery-blocking plaque deposits.

The American Heart Association recommendation is that "if you drink, do so in moderation." That means one to two drinks a day for a man, one drink a day for a woman, with a drink defined as 12 ounces of beer, 4 ounces of wine or 1 ounce of 100-proof spirits.

Every 34 seconds an American will suffer a heart attack according to the American Association for Critical Illness Insurance

SOURCES: Eric B. Rimm, Sc.D., associate professor, epidemiology and nutrition, Harvard School of Public Health, Boston; Kenneth Mukamal, M.D., internist, Beth Israel Deaconess Hospital, associate professor, medicine, Harvard Medical School, Boston; Nov. 19, 2009, Heart, online.

Friday, November 20, 2009

Diuretics Still Best Treatment for High Blood Pressure

Diuretics are confirmed as the best first-line treatment in older men and women with high blood pressure according to new research.

Medical researchers reported the findings of a study at the annual meeting of the American Heart Association this week.   They reported that the thiazide-type diuretic chlorthalidone outshone three other treatments -- a calcium channel blocker, an ACE inhibitor and an alpha-receptor blocker -- in most areas.  This was especially effective in lowering the incidence of stroke and heart failure.

An estimated 80 million American adults have one or more types of cardiovascular disease according to the American Association for Critical Illness Insurance.  Some 785,000 will have a new coronary attack this year according to the industry trade group. 

The findings the medical experts note are largely unchanged.  They note that the main message is that treating hypertension [high blood pressure] is very necessary and that treating hypertension with chlorthalidone resulted in a significant reduction in heart failure and stroke. 

The original trial, begun in 1994, involved more than 42,000 patients with hypertension and at least one other risk factor for cardiovascular disease. The participants were randomly assigned to take one of the following anti-hypertensive drugs: chlorthalidone (the diuretic), amlodipine besylate (the calcium channel blocker), doxazosin mesylate (the alpha blocker) or lisinopril (an ACE inhibitor). 

The five-year follow-up, which ended in 2002, was intended to see if new differences emerged with long-term use of the medications, especially regarding coronary heart disease, total mortality, heart failure and aggregate cardiovascular disease. 

This is the largest hypertension trial to date, one researcher noted.  Earlier results had also found that diuretics were as good or better than other blood pressure-lowering drugs for treating hypertension in patients with metabolic syndrome (a collection of factors that put people at risk of heart disease), especially black patients.

Thursday, November 19, 2009

Migraine Increases Likelihood Of Stroke New Study Reports

People who suffer migraines have more than double the risk of ischemic stroke, and the risk is especially high in women.

Ischemic stroke, the most common type of stroke, occurs when blood supply to the brain is cut off by plaque accumulation or a blood clot.

In astudy presented at the American Heart Association's annual meeting in Orlando, Florida, researchers from Johns Hopkins University School of Medicine reviewed the findings of 21 studies that included a total of 622,381 men and women, aged 18 to 70, in Europe and North America.

Those with migraines were 2.3 times more likely than people without migraines to suffer ischemic stroke. The risk was 2.5 times higher for migraine sufferers who experienced aura (visual disturbances such as flashing lights, zigzag lines and blurred vision), and for women experiencing aura, 2.9 times higher.

The findings reinforce the link between migraine and stroke and also correct some discrepancies in previous analyses that yielded mixed results, according to Hopkins cardiologist and senior study investigator Dr. Saman Nazarian.

Nazarian said nearly 1,800 articles have been written about the relationship between migraine and stroke, but the Hopkins review is believed to be the largest of its kind and was more selective, including only studies that used similar designs and groups of people.

"Identifying people at highest risk is crucial to preventing disabling strokes. Based on this data, physicians should consider addressing stroke risk factors in patients with a history or signs of light flashes and blurry vision associated with severe headaches," Nazarian said in a Hopkins news release.

There are a number of migraine prevention and treatment options, including smoking cessation, taking medications to lower blood pressure or taking blood-thinning drugs such as aspirin, Nazarian added. For women with migraines, additional options include discontinuing use of birth control pills or stopping hormone replacement therapy.

For information on critical illness insurance visit the website of the American Association for Critical Illness Insurance where you can obtain free, no obligation costs for this important protection.

Wednesday, November 18, 2009

Rapid Cooling May Help When Heart Attack Hits

Rapid cooling of heart attack patients may boost their chance of survival without brain damage.

Swedish researchers examined the use of a device called RhinoChill, which cools the brains of heart attack patients during ongoing cardiopulmonary resuscitation (CPR).

The median time between cardiac arrest onset and the start of cooling was 23 minutes. On arrival at hospital, the average body temperature of cooled patients was 93.56 degrees F, compared with 95.9 degrees for standard care patients.

The study found that 46.7 percent of patients in the cooling group survived to hospital discharge, compared with 31 percent of patients who received standard care.   In addition, some 36.7 percent of those in the cooling group and 21.4 percent of those in the standard care group were in good neurological condition when discharged from the hospital.

Patients who received a combination of early CPR -- started within six minutes of collapse -- and cooling had the best outcomes.   The researchers noted that the earlier you can do the cooling, the better. When resuscitation efforts were delayed, there was no significant difference in survival. 

The study was to be presented Nov. 15 at an American Heart Association's annual meeting in Orlando, Fla.

According to the American Association for Critical Illness Insurance, some785,000 Americans will have a new cornary attack this year.

Wednesday, November 11, 2009

Study Drug Shrinks Lung Cancer Tumors In Mice

A potential new drug for lung cancer has eliminated tumors in 50% of mice.

Researchers report that the drug also stopped lung cancer tumors from growing and becoming resistant to treatment. 

One in five people with lung cancer have small cell lung cancer and only three per cent of these people are expected to survive for five years. With this form of lung cancer, tumors spread quickly so it is rarely possible to remove the tumors surgically. Because of this, small cell lung cancer is treated with chemotherapy, with or without additional radiotherapy.

Initially, the treatment often appears to work, reducing the size of the tumors. However, the tumors usually grow back rapidly and then become resistant to further treatment.

The researchers have identified a drug that, in some mice, was able to completely shrink tumors away. In the mouse models, it was also able to stop tumors from growing and it helped other forms of chemotherapy to work more effectively. If the drug proves successful in humans, the researchers hope that it could help patients with this kind of lung cancer to live longer.

The Section of Molecular Oncology and Lung Cancer Research at Imperial College London which conducted the study suggests that it may be possible to develop the drug PD173074 into a new targeted therapy for small cell lung cancer. We hope to take this drug, or a similar drug that also stops FGF-2 from working, into clinical trials next year to see if it is a successful treatment for lung cancer in humans. An added bonus of this drug is that it could be taken orally, which would make it less invasive than some other forms of cancer therapy.

Lung cancer is one of the most common cancer killer in the world according to the American Association for Critical Illness Insurance.   Around one in five of people diagnosed with lung cancer will have small cell lung cancer. Although it responds to chemotherapy initially, the tumors soon become resistant to treatment and sadly nearly all people with the disease do not survive.

The Cancer Treatment and Research Trust, Cancer Research UK and the UK Department of Health funded the research. 

Free Membership Offer For Insurance Agents Ends Soon

The American Association for Critical Illness Insurance was established to build the market and sale of critical illness insurance products in the United States.

Launched in 2009, the organization recently unveiled an Online Learning, Marketing & Sales Center which is available exclusively to members of the organization.

As part of the launch, the organization offered free membership to all insurance and financial professionals.  The free offer ends December 31, 2009.  Those joining prior to that date will be members of the organization through December 31, 2010.

Starting in January 2010, the cost of membership in the organization will be $49 per-year.

For more information or to access the online sign-up page, go to:
http://www.criticalillnessinsuranceinfo.org/sales-center/

Breast Cancer Cured But Pain Survives

Nearly half of breast cancer survivors suffer from persistent pain.

According to a report in today's Journal of the American Medical Association the pain exists even two or three years following treatment.  Almost 60% of the over 3,000 women surveyed experience other symptoms of nerve damage, such as numbness or tenderness, according to a study of women treated for breast cancer in 2005 and 2006.

The researchers noted that women under 40 and those who have more extensive surgery, such as a mastectomy, and radiation are the most likely to report pain.  Women, they report, also have more pain if surgeons removed many of the lymph nodes in their armpits, a common place for breast cancer to spread.

Most breast cancer patients can ease their symptoms with over-the-counter pain relievers.  Every year nearly 700,000 American women are diagnosed with cancer according to the American Association for Critical Illness Insurance.  About one in four women are diagnosed with breast cancer and as a result of early detection and improved treatment, most survice. 

While the medical experts explain that it is not always possible to prevent chronic pain, there are ways women can reduce their risk. 

Women should choose doctors who perform "sentinel-node" biopsies, one of the experts writing in the Journal noted. In the procedure, surgeons remove and test one or a few key lymph node for malignant cells instead of automatically removing all of the nodes. If the sentinel node is cancer-free, surgeons leave the others in place. The procedure also reduces the risk of lymphedema, a painful swelling in the arm.

Monday, November 9, 2009

Walking And Exercise May Lower Prostate Cancer Risk

Men who regularly get moderate exercise may have a lower risk of developing prostate cancer. 

Researchers examined men who underwent biopsies for possible prostate cancer.  Those who exercised moderately, the equivalent of three to six hours of walking per week, were less likely to be diagnosed with the disease. 

The study found that compared with their sedentary counterparts, these men were two-thirds less likely to have a biopsy positive for prostate cancer. In addition, men who performed one to three hours of walking each week had an 86 percent lower chance of having an aggressive form of the cancer. 

According to the American Association for Critical Illness Insurance, some 745,000 men are diagnosed with cancer each week.  Prostate cancer is the leading cancer impacting men.  The study findings which appear in the current issue of the Journal of Urology do not prove that exercise helps prevent prostate cancer the researchers point out. But it could offer men another incentive to get active. 

A number of studies have looked at the relationship between exercise and prostate cancer, and while most have pointed to a protective effect, about one-third have found no association.  The medical experts found that among the 111 sedentary men in the study, half were diagnosed with cancer after biopsy. That compared with 27 percent of those men who got the equivalent of three to six hours of walking each week. 

And among men diagnosed with prostate cancer, 51 percent of sedentary patients had more-aggressive cancer, versus 22 percent of those who had been mildly active -- getting the equivalent of one to three hours of moderate walking per week.

Exercise itself remained linked to a lower risk of prostate cancer after the researchers accounted for a number of other factors, like age, weight and race.  Exercise has been shown to lower blood levels of testosterone and other hormones that may stimulate prostate tumor growth. Exercise is also believed to stimulate the immune system and the body's natural antioxidant mechanisms, both of which may help prevent the development of prostate cancer.

More Adults At Risk Of Heart Disease

Only 7.5 percent of Americans are now in the clear when it comes to heart disease risk factors according to a new study.

Resaerchers found that several decades of steady reductions in heart disease may be on the wane.  The obesity epidemic affecting millions of Americans bears much of the blame for the increased risk.  As a result, the decline in cardiovascular disease mortality in the U.S. seems to be coming to an end and may even reverse itself.

A worsening cardiovascular risk profile in the population could potentially lead to increases in the incidence and prevalence of cardiovascular disease, noted researchers from the U.S. Centers for Disease Control and Prevention.   The increases in cardiovascular disease and diabetes will affect the nation's medical costs, stated Jesse Slome, director of the American Association for Critical Illness Insurance.  Medical costs account for two-thirds of all U.S. bankruptcies, he noted.

The researchers collected data on adults 25 to 74 years of age looking for low-risk factors for heart disease.  These include items such as not smoking, having low blood cholesterol, normal blood pressure, normal weight and no sign of diabetes.

Using data from the U.S. National Health and Nutrition Examination Surveys, the study found that in 1971 to 1975, a paltry 4.4 percent of adults had all five of these heart-healthy factors. However, by 1994 that number had risen to 10.5 percent of adults. 

The latest data, from 2004, found that the fraction of American adults with all five healthy characteristics had dropped to 7.5 percent.  Minorities tended to fare worst, since whites tended to have more low-risk factors than either blacks or Mexican-Americans, the report found.

The reserachers identified three reasons for the backslide in health; decreases in the percentages of adults who were not overweight or obese, a decrease in those who had a favorable blood pressure, and an increase in the number who have diabetes.  There was one bright spot in the report, a decrease in the percentage of adults who were not currently smoking.

Because excess weight is a major cause of diabetes and hypertension, it is critical that the percentage of adults who are overweight or obese be reduced, the researchers noted.  "This alarming development is occurring despite great improvements in medical interventions to prevent cardiovascular diseases," he said. "It is of particular concern that these trends do not yet reflect the consequences of the current epidemic of childhood obesity."

If these trends continue, the recent gains in life expectancy in the U.S. will be lost, the medical experts noted.

The study was published in the Sept. 14 online edition of Circulation.

SOURCES: Earl S. Ford, M.D., M.P.H., U.S. Centers for Disease Control and Prevention, Atlanta; Rob M. van Dam, Ph.D., assistant professor, medicine, Harvard Medical School; Boston; Gregg C. Fonarow, M.D., professor, cardiology, University of California, Los Angeles; Sept. 14, 2009, Circulation, online.

Sunday, November 8, 2009

Eating Red Meat Linked To Prostate Cancer

Men who consumer red meat or processed red meats may have a higher risk of developing prostate cancer than those who limit such foods.

Researchers at the National Cancer Institute report the findings of a major study.  Researchers followed more than 175,000 men for nine years.  Those who ate the most red and processed meats had heightened risks of developing any stage of prostate cancer, or advanced cancer in particular.  Prostate cancer is the most commong cancer in men according to the American Association for Critical Illness Insurance, followed by lung and colon. 

The findings which were reported in the American Journal of Epidemiology add to a conflicting body of research on meat intake and prostate cancer risk.   Prior studies have come to different conclusions.  However, medical experts generally consider the evidence linking red and processed meats to the disease to be limited and inconclusive. 

These latest findings do not settle the question. The researchers explain that they do suggest that processed red meats and high-heat cooking methods -- namely, grilling and barbecuing -- may be particularly connected to prostate cancer risk. 

The researchers followed 175,300 U.S. men between the ages of 50 and 71 who were surveyed about their diets.  Specifically, the study looked at how much and what type of meat the participants typically ate.  They also studied the cooking methods used.

The researchers used that information to estimate the levels of certain potentially cancer-promoting chemicals in the men's diets.  Over the next nine years, 10,313 study participants developed prostate cancer and 419 died from the disease. 

Overall, the researchers found, the 20 percent of men with the highest intakes of red meat, which in this study included beef and pork, were 12 percent more likely than those who consumed the least to develop prostate cancer. That's after a range of other factors, like smoking, exercise habits and education, were taken into account. 

There was a stronger connection to advanced prostate cancer -- with that risk being almost one-third higher among those who ate the most red meat versus those who ate the least. 

Similar findings were seen with processed meat. But when the researchers broke the men's diet information down further, they found that red processed meats -- like bacon and red-meat sausage and hot dogs -- were related to higher prostate cancer risk, while white processed meats, like poultry cold cuts, were not. 

When it came to cooking methods, the only one that was linked to prostate cancer was grilling or barbecuing.

The finding is in line with the theory that meats cooked at high temperatures may be particularly linked to cancer because the cooking process produces certain chemicals -- including polycyclic aromatic hydrocarbons (PAHs) and heterocyclic amines -- that are known to cause cancer in animals. 

The researchers also found that higher dietary levels of a PAH called benzo-alpha-pyrene were related to a higher risk of prostate cancer. A similar pattern emerged when the investigators looked at men's intake of nitrites and nitrates -- chemicals used to preserve and flavor processed and cured meats like ham, bacon and sausage.  In the body, nitrites and nitrates can promote the production of potentially cancer-promoting chemicals called nitrosamines.

Saturday, November 7, 2009

Obesity Causes 100,000 U.S. Cancer Cases

Obesity causes more than 100,000 cases of cancer in the United States each year according to a report from the American Association for Critical Illness Insurance, creating a greater financial strain on health insurance companies and American families. 

Researchers estimate that obesity-related diseases account for nearly 10 percent of all medical spending in the United States or an estimated $147 billion a year.  Cancer is the second-leading cause of death in the United States after heart disease. The American Cancer Society reports that nearl 1.5 million people will be diagnosed with cancer this year and 562,000 will die of the disease. 

Medical researchers at the American Institute for Cancer Research reported that having too much body fat causes nearly half the cases of endometrial cancer, which is a type of cancer of the uterus.  Too much body fat they note was also responsible for one third of esophageal cancer cases.

The researchers expect the number of cancer cases will likely rise as Americans get fatter.  Nearly a third of Americans are overweight, defined as having a BMI of 25 to 30.  

More than 26 percent of Americans are obese, defined as having a body mass index of 30 or higher. BMI is equal to weight in kilograms divided by height in meters squared. A person 5 feet 5 inches tall becomes obese at 180 pounds (82 kg). 

The American Institute for Cancer Research reported the percented of cancer cases that would be prevented if everyone in the United States maintained a healthy weight.  Here are some of its estimates of cancer types that could be prevented annually if Americans stayed slender:

Endometrium - 49 percent of cases or 20,700 people

Esophageal - 35 percent of cases or 5,800 people

Pancreatic - 28 percent or 11,900 people

Kidney - 24 percent or 13,900 people

Gallbladder - 21 percent or 2,000 people

Breast - 17 percent or 33,000 people

Colon - 9 percent or 13,200 people

 

Thursday, November 5, 2009

Race, Income, Marital Status Has No Impact On Prostate Cancer Outcome

A patient's income, martial status and race has absolutely no impact on their outcome following curative radiation therapy for the treatment of prostate cancer.

A study conducted at the Henry Ford Hospital in Detroit found that socioeconomic status factors had no impact on predicting the outcome of treatment. All patients did equally well, based on the known prognostic factors.

The study, presented this week at the American Society for Radiation Oncology meeting in Chicago is unique in that nearly 50 percent of patients in the analysis are African American.

Prostate cancer affects one in six men in the United States according to the American Association for Critical Illness Insurance and the majority of all prostate cancer are diagnosed in men older than 65.  Most individuals diagnosed with the illness will survive.  Only one in 35 will die of prostate cancer.   Radiation therapy involves administering high-energy X-rays to kill cancer cells. 

According to the study's lead researcher, prior studies on socioeconomic status and cancer outcomes done by other groups have had conflicting results.  One study, for example, suggested that African Americans with breast or colon cancer do much worse than white patients because they receive care at hospitals with less expertise. 

Another study the medical experts noted show that men with prostate cancer who are married have better outcomes than those who are unmarried or without a partner. And yet other studies suggested that hospitals with large minority patient populations have higher mortality for cancer.

A shortcoming of many of the studies is the fact that they include a relatively small percentage of African American patients.  By comparison, almost half of the Ford study group was African American, which allowed researchers to undertake a more accurate assessment of how socioeconomic status affects prostate cancer outcomes.

The study included 788 Henry Ford Hospital patients with localized prostate cancer who were treated with external beam radiation therapy. Among those in the study, 48.5 percent were African American with a median household income $36,917, and 46 percent were white with a median household income of $60,190. The patients' ages ranged from 44 to 90.

While there was a large difference in median household income among African Americans and whites, none of the socioeconomic factors examined predicted for patient outcome. Only known disease risk factors determined overall survival or biochemical (PSA) control rates.

Wednesday, November 4, 2009

Low Cholesterol Could Be Sign Of Cancer In Men Especially

Low total cholesterol may be a sign of cancer according to researchers.

Previously, some medical experts had thought that low cholesterol may have been a cause.  According to researchers reporting this week, findings suggest that men who have low cholesterol actually have a lower risk of developing high-risk prostate cancer.

There were some 1.4 million cancer cases in the United States last year according to the American Association for Critical Illness Insurance.  The cost of caring for medical conditions caused over 60 percent of the 1.5 million Americans to declare bankruptcy. 

A study of more than 5,000 U.S. men conducted by Johns Hopkins University in Baltimore found a link between low cholesterol and a lower risk of high-grade prostate cancer among men over age 55.

The researchers report that if men had total cholesterol of less than 200 milligrams/deciliter, they had a nearly 60 percent lower risk of developing high-grade prostate cancer, the riskiest kind. 

It is not clear whether taking cholesterol-lowering statin drugs might help men with prostate cancer. That would need to be studied, the medical experts noted.  The study was reported in the journal Cancer Epidemiology, Biomarkers & Prevention. 

For years, researchers had noticed that people who have lower total cholesterol -- a combination of both low-density lipoprotein or LDL, the "bad" kind, and high-density lipoprotein or HDL, the "good" kind -- appeared more likely to have certain types of cancers than other people. 

They report this finding was worrisome because having low cholesterol, and particularly low levels of "bad" LDL cholesterol, has been shown to protect against heart attacks and strokes. 

An expert at the National Cancer Institute, part of the National Institutes of Health, said in a statement, "The study affirms that lower total cholesterol may be caused by undiagnosed cancer.  In terms of a public health message, we found that higher levels of 'good' cholesterol seem to be protective for all cancers." 

An 18-year study of nearly 30,000 Finnish male smokers, the largest and longest of its kind, found that over the nearly two decades some 7,545 men developed cancer.  The men with lower total cholesterol levels -- below 230 milligrams/deciliter -- had an 18 percent higher risk of cancer overall. 

But, when the researchers excluded cancers that occurred in the first nine years of the study, this risk disappears.  The findings the researchers notes support the idea that the lower serum total cholesterol level we detected as a possible cancer risk factor may actually have been the result of undiagnosed cancers.

Monday, November 2, 2009

Study Reports Cholesterol Medicines Effective Against Cancer

Research shows that medicines based on statins used to lower blood cholesterol may also be effective in the treatment of cancer.

Statins lower cholesterol by blocking certain enzymes involved in metabolism.   Medical experts note that  they have also been shown to help proteins attach to cell membranes.  Because many of the proteins that are lipid-modified cause cancer, there are now hopes that it will be possible to use statins in the treatment of cancer.

Researchers at the University of Gothenburg, Germany, conducted studies that show statins can have a dramatic inhibitory effect on growth and development.  The researchers note that their results support the idea that statins can be used in more ways than just to lower cholesterol.  Not least that they can prevent the growth of cancer cells caused by lipid-modified proteins, but also that they can be effective in the treatment of diabetes and neurological disorders such as Parkinson's. 

The findings were published in the article Statins Inhibit Protein Lipidation and Induce the Unfolded Protein Response in the Non-Sterol Producing Nematode C. elegans, published in the journal PNAS.  The study is the result of a research partnership between the University of Gothenburg, Chalmers University of Technology.

Information on critical illness is gathered and posted by the American Association for Critical Illness Insurance, the national trade organization focused on helping individuals understand the importance of protecting their financial futures.

Sunday, November 1, 2009

Low Vitamin D Linked To Heart, Stroke Deaths

Low vitamin D levels in the may be deadly causing a higher risk of death from heart disease or stroke.

According to the American Association for Critical Illness Insurance, the non-profit industry organization, some 785,000 Americans will have a new coronary attack this year.  From 1995 to 2005, the death rate from coronary heart disease declined 34 percent. 

The new study published in the American Journal of Epidemiology reports that adults with lower, versus higher, vitamin D levels in their blood may be more likely to die from heart disease or stroke.

Vitamin D is an essential vitamin mostly obtained from direct sunlight exposure, but also found in foods and multivitamins. Researchers at the National Institute for Health and Welfare in Helsinki, Finland compared blood levels of vitamin D and deaths from heart disease or stroke over time in several thousand men and 3,402 women.

Participants were just over 49 years old on average at the beginning of the research and had no indicators of cardiovascular disease. During follow-up of about 27 years on average, 640 of the participants (358 men) died from heart disease and another 293 (122 men) died from stroke. Compared with participants' with the highest vitamin D, those with the lowest had 25 percent higher risk of dying from heart disease or stroke, the researchers noted.

There was a "particularly striking association" between vitamin D levels and stroke deaths, they explain. Those having the lowest vitamin D seemed to confer "twice the risk," compared with those having the highest vitamin D. Allowing for age, gender, and other demographic factors, plus alcohol intake, smoking, physical activity, and season in which vitamin D levels were obtained did not significantly alter these associations.

In this study, vitamin D levels were "substantially lower" than levels thought to be sufficient, and "somewhat lower" than those reported in previous studies in other European and American populations.

Saturday, October 31, 2009

High-def Colonoscopy Detects More Polyps

A high-definition (HD) colonoscopy is much more sensitive than standard colonoscopy in finding polyps that could morph into cancer.

According to researchers from the Mayo Clinic it appears that high-definition colonoscopy detects more precancerous polyps. The difference could be as much as 20 percent.

Approximately 14 million colonoscopies are performed each year according to the American Association for Critical Illness Insurance, the industry organization that tracks and reports data related to critical illnesses. Some 745,000 men were diagnosed with cancer each year, roughly 10 percent with colon cancer.

 A study was conducted between September 2006 and December 2007 when the Mayo Clinic in Florida was switching its six colonoscopy procedure rooms from standard colonoscopy endoscopes to high-definition endoscopes.

The findings, presented at the annual meeting of the American College of Gastroenterology in San Diego, Calif., are not only important because a large group (2,430) of patients participated, but they resulted from the only study to date that has compared these two methods in a general clinical practice setting, among all the patients who needed a colonoscopy and with all the physicians who performed it.

An endoscope is the lighted tube inserted into the colon and rectum to look for, and remove, polyps. A high-definition endoscope uses both a high-definition video chip and HD monitors (like HD television) that increase the resolution of the image. Patients were not assigned to one scope or the other. Instead, they were placed in whatever room was available and assigned a gastroenterologist who was on duty at the time.

Researchers found that the rate of detection of adenomas -- polyps that are likely to become cancerous -- was 29 percent among patients who were scanned with high-definition endoscopes, versus 24 percent for those in which standard endoscopes were used.

The study was funded by Mayo Clinic, and the authors declare no conflict of interest nor do they endorse the products mentioned in the study.

Friday, October 30, 2009

Fitness Level, Not Body Fat, Stronger Predictor Of Longevity After 60

Want to live longer?  Focus on fitness.  A study reveals that adults over age 60 who had higher levels of cardiorespiratory fitness lived longer than unfit adults, independent of their levels of body fat. 

Prior studies have provided evidence that obesity and physical inactivity each can produce a higher risk of death in middle-aged adults. Whether this is also true for older adults is uncertain, according to background information in the article.

According to the American Association for Critical Illness Insurance, which tracks important developments and news that can help Americans remain healthy and avoid critical illness including heart disease, stroke and cancer, Medical researchers at the University of South Carolina, Columbia examined the associations between cardiorespiratory fitness, various clinical measures of adiposity (body fat) and death in older women and men. The study included 2,603 adults age 60 years or older (average age, 64.4 years; 19.8 percent women) enrolled in the Aerobics Center Longitudinal Study who completed a baseline health examination during 1979-2001. Fitness was assessed by a treadmill exercise test and adiposity was assessed by body mass index (BMI), waist circumference, and percent body fat. Low fitness was defined as the lowest fifth of the sex-specific distribution of treadmill exercise test duration. There were 450 deaths during an average follow-up of 12 years. 

The researchers found that those who died were older, had lower fitness levels, and had more cardiovascular risk factors than survivors. However, there were no significant differences in adiposity measures. Participants in the higher fitness groups were for the most part less likely to have risk factors for cardiovascular disease, such as hypertension, diabetes, or high cholesterol levels. 

Fit participants had lower death rates than unfit participants within each stratum of adiposity, except for two of the obesity groups. In most instances, death rates for those with higher fitness were less than half of rates for those who were unfit. 

Higher levels of fitness were inversely related to all-cause death in both normal-weight and overweight BMI subgroups, in those with a normal waist circumference and in those with abdominal obesity, and in those who have normal percent body fat and those who have excessive percent body fat. 

The data provided further evidence regarding the complex long-term relationship among fitness, body size, and survival. It may be possible to reduce all-cause death rates among older adults, including those who are obese, by promoting regular physical activity, such as brisk walking for 30 minutes or more on most days of the week (about 8 kcal/kg per week), which will keep most individuals out of the low-fitness category. Enhancing functional capacity also should allow older adults to achieve a healthy lifestyle and to enjoy longer life in better health, they noted.

 

Thursday, October 29, 2009

Migraine Headaches With Aura Can Double Stroke Risk

Young women who smoke and use birth control pills may be susceptible to getting migraine headaches with aura.

Medical researchers advise that those with the combination of conditions should stop smoking and using birth control pills because new findings reveal they may increase their risk of stroke.

People who suffer migraine headaches with aura experience visual disturbances before or during the migraine.  For these individuals, the medical scientists found that the risk for ischemic stroke is doubled. Being female, under 45, smoking and using oral contraceptives that contain estrogen added to the risk.   Studies were conducted at Brigham and Women's Hospital in Boston.

According to the American Association for Critical Illness Insurance, the national organization that tracks data on strokesm heart attacks and cancer, an ischemic stroke is caused by a blockage in a blood vessel. The connection between migraine and stroke was already suspected executives note. What was unknown was the extent of risk and who is most at risk. 

Migraine headaches affect up to 20 percent of the U.S. population. Women are up to four times more likely than men to get migraines, and as many as one third also experience an aura before or during a migraine. 

Migraine with aura is associated with a twofold increased risk for ischemic stroke compared to people without migraine.  The report notes that migraine without aura does not appear to change the risk. 

The report is published in the Oct. 27 online edition of the British Medical Journal confirms that the risk appears to be highest among women with migraine with aura who smoke and use oral contraceptives.  The medical reserachers add that migraine alone does not appear to alter the risk for heart attack and death from cardiovascular disease.

Wednesday, October 28, 2009

Women Have More Heart Attacks; Survival More Likely

Hearts attacks among middle-aged American women have increased over the past two decades.  That news is accompanied by a report that their chance of survival has improved.

Two new studies reveal that men still have a higher prevalence of heart attack than women.  Medical researchers report that the gap has narrowed as heart attacks among women have increased while they have decreased among men.

A study by researchers at the University of Southern California revealed that 2.5 percent of the men and 0.7 percent of the women reported a history of heart attacks in the prior surveys.  In the more recent study, they found 2.2 percent of men and 1 percent of women reported heart attacks.

 Every 34 seconds an American will suffer a heart attack according to the American Association for Critical Illness Insurance.  Some 785,000 Americans will have a new coronary attack and nearly half a million will have a recurrent attack. 

The narrowing of the male-female difference is easily explained, according to medical experts.  They point to the fact that risk factors are being better controlled in men than in women.  In men, levels of "bad" LDL cholesterol remained the same between the two surveys, while levels of "good" HDL cholesterol improved. Blood pressure levels improved, and fewer men smoked. 

Researchers noted that the improvements for women were marginal, with LDL cholesterol levels about the same. The only risk factor that improved in women was HDL cholesterol. Diabetes and obesity increased in both men and women, the study found. 

They noted that societal changes may play a role.  With more women in the work force, rising rates of obesity and diabetes can be attributed to job demands.   

A second study used information from a different data bank listing death rate trends from 1994 to 2006. Researchers found a marked reduction in hospital deaths from heart attacks in all patients, especially among women. For women under 55, the risk of dying dropped by 53 percent, which was the greatest improvement noted. The least reduction, 33 percent, was seen in men under 55. 

The studies are reported in the October 26 issue of Archives of Internal Medicine.

 

Tuesday, October 27, 2009

Drinking Coffee May Slow Development Of Liver Disease

Coffee slows the progression of advanced liver disease in people with chronic hepatitis C.

New research published in the November issue of the journal Hepatology reveals information on the first study to address the association between liver disease progression related to hepatitis C and coffee intake. 

Researchers studies nearly 800 patients infected with hepatitis C virus (HCV) who were asked to report their intake of coffee, green tea and black tea. The patients were seen every three months during the nearly four-year study, and liver biopsies were taken at 18 months and 3.5 years to determine the progression of liver disease. 

Patients who drank three or more cups of coffee per day were 53 percent less likely to have liver disease progression than those who didn't drink coffee. Green and black tea didn't appear to have an effect, but tea consumption was low among the study participants, the researchers noted in the report. 

Given the large number of people affected by HCV, the researchers noted the importance of identifying modifiable risk factors associated with the progression of liver disease.  Although we cannot rule out a possible role for other factors that go along with drinking coffee, results from our study suggest that patients with high coffee intake had a lower risk of disease progression, the study concluded.

HCV infects about 2.2 percent of the worldwide population, including more than 3 million Americans according to the Ameriocan Association for Critical Illness Insurance. The virus is the leading cause of liver transplantation in the United States and is responsible for 8,000 to 10,000 deaths in the country each year, according to the U.S. Centers for Disease Control and Prevention.

Monday, October 26, 2009

Link Between Depression And Kidney Disease Identified

A new study finds that one in five patients with chronic kidney disease is depressed, even before beginning long-term dialysis therapy or developing end-stage renal disease.

Researchers at UT Southwestern Medical Center conducted the first study to examine the relationship. Medical experts have noted that patients in the early stages of chronic kidney disease are at increased risk for clinical depression according to the study in the current issue of the American Journal of Kidney Diseases.

According to the American Association for Critical Illness insurance, some 26 million Americans have chronic kidney disease and millions more are at increased risk. If treatment does not begin early, the condition progresses to end-stage renal disease. At that point, a patient's kidneys have failed to the point where dialysis is needed. Dialysis involves filtering of toxic chemicals in the blood and removing fluid to help control blood pressure.

Previous research has shown that depression rates in the general community are 2 percent to 4 percent. Among diabetes patients, the rate is 11 percent. Among congestive heart failure patients, 14 percent; and among coronary artery disease after heart attack patients, 16 percent.

Chronic kidney disease patient depression numbers may be higher due to the presence of the same simultaneously occurring conditions that resulted in progressive kidney disease, such as diabetes and atherosclerotic vascular disease, one of the researchers noted.

Some 21 percent of those studied by researchers were found to be depressed. The mean age of depressed patients was about 65. The researchers also found that diabetic patients were twice as likely to be depressed as those without diabetes; 63 percent of patients had at least three other medical conditions; and 41 percent had at least four other diseases.

Expenditures for end-stage renal disease patients totaled $15.5 billion, which is approximately 6 percent of the entire Medicare budget, and are projected to consume $28 billion by 2010.

For more information on critical illness insurance and to learn the cost for this protection, visit the website of the American Association for Critical Illness Insurance where you can access a free cost calculator to look up rates for coverage starting at $10,000 and increasing to $50,000.

Saturday, October 24, 2009

Breast Cancer Hits Well Educated Women Hardest By Breast Cancer

Well-educated women are emotionally the hardest hit by breast cancer.

A study undertaken by Australia's Monash University Medical School's Women's Health Program, found that well-educated women and those who live alone are emotionally the hardest hit. 

Nearly 1.5 million Americans will be diagnosed with cancer in 2010 according to the American Association for Critical Illness Insurance, the industry trade group, including almost 180,000 breast cancer cases in women.  Breast cancer is the most common cancer among women. With improvements in detection and treatment of breast cancer, 87 per cent of women affected survive five years or more from the time of detection.

The researchers found that two years post diagnosis women with breast cancer were not more likely to be depressed but were more likely to experience a lowered sense of control over their life, and lower general health, with lessened vitality being limited to older women.

Women living alone were more likely to have a lower well being is an important finding suggesting that such women may benefit by targeted provision of social support.   

The study reported that women's well being two years out from being treated for the disease was overall only modestly lower than for women in general. 

Posted by Jesse Slome
For information on long-term care coverage, visit the American Association for Long-Term Care Insurance.

Friday, October 23, 2009

Researchers Find Stroke Treatment Allows More Time

Researchers have found that treatment of stroke sufferers are effective within four and a half hours rather than the three hour time period previously recommended.

Every 40 seconds, an American has a stroke according to the American Association for Critical Illness Insurance, the non-profit, Los Angeles based industry professional organization.  Some 600,000 people will have their first stroke explains Jesse Slome, executive director.

Tissue plasminogen activator (tPA) treatment benefits stroke patients when used up to 4.5 hours after a stroke, according to German researchers who said their findings provide further evidence to increase the tPA treatment window from the current three hours to 4.5 hours.

Previously published findings indicated that tPA treatment led to better outcomes than placebo in stroke patients treated from three hours to 4.5 hours post-stroke.

In this new study, medical researchers at the University of Heidelberg, and colleagues conducted a secondary analysis of data using different endpoints. They focused on the efficacy and safety of tPA treatment and also looked for any factors or patient subgroups that might affect treatment outcome.

The study included patients who received alteplase from three hours to 4.5 hours after a stroke, and patients who received a placebo. The results showed a clear benefit from treatment with alteplase in all types of patients, including those younger and older than 65 years, men and women, and those with or without a history of diabetes, stroke or high blood pressure.

The researchers also found that alteplase was beneficial, regardless of the severity of the stroke.

The study was released online in advance of publication in the December print issue of The Lancet.   Medical experts explain that a physician must, as always, diligently undertake a careful history and physical examination, look at the non-contrast brain CT scan carefully, and follow the appropriate protocol. All of these steps will result in substantial benefit to public health and will safely benefit many patients. But 'time is brain,' and therapy must be given as soon as possible after the patient arrives and there is indeed not a moment to lose, they add.     SOURCE: The Lancet, news release, Oct. 20, 2009.

Researchers Report Tie Between Depression And Chronic Kidney Disease

A new study finds that one in five patients with chronic kidney disease is depressed, even before beginning long-term dialysis therapy or developing end-stage renal disease.

Researchers at UT Southwestern Medical Center conducted the first study to examine the relationship. 

Medical experts have noted that patients in the early stages of chronic kidney disease are at increased risk for clinical depression according to the study in the current issue of the American Journal of Kidney Diseases.

Previous research has shown that depression rates in the general community are 2 percent to 4 percent.  Among diabetes patients, the rate is 11 percent.  Among congestive heart failure patients, 14 percent; and among coronary artery disease after heart attack patients, 16 percent.

Chronic kidney disease patient depression numbers may be higher due to the presence of the same simultaneously occurring conditions that resulted in progressive kidney disease, such as diabetes and atherosclerotic vascular disease, one of the researchers noted.  Patients such as diabetics, who are depressed, may develop progressive kidney disease because of non-adherence to medications and physicians' advice.

From May 2005 to November 2006, researchers invited patients at the Dallas VA Medical Center who were visiting the clinic for chronic kidney disease appointments to join the study. Patients who agreed to participate then underwent a structured clinical interview to determine if they had a current major depressive episode, based on the DSM IV definition of major depressive disorder.

Some 21 percent were found to be depressed. The mean age of depressed patients was about 65.  The researchers also found that diabetic patients were twice as likely to be depressed as those without diabetes; 63 percent of patients had at least three other medical conditions; and 41 percent had at least four other diseases.

According to the American Association for Critical Illness Insurance, some 26 million Americans have chronic kidney disease and millions more are at increased risk. If treatment does not begin early, the condition progresses to end-stage renal disease. At that point, a patient's kidneys have failed to the point where dialysis is needed.  Dialysis involves filtering of toxic chemicals in the blood and removing fluid to help control blood pressure.

Expenditures for end-stage renal disease patients totaled $15.5 billion, which is approximately 6 percent of the entire Medicare budget, and are projected to consume $28 billion by 2010.

Wednesday, October 21, 2009

Protein May Predict Heart Attack

October 21, 2009.  People with high levels of a protein called C-reactive protein may be at higher risk for heart attack. 

According to a study published in the medical journal of the American Academy of Neurology the C-reactive protein (CRP), a marker for inflammation in the blood, may predict those at higher risk for heart attack and death but not stroke.

 The study involved over 2,200 people who were 40 years old or older and stroke-free.  All participants had their blood tested for CRP levels and were evaluated for stroke and heart attack risk factors.

Participants were followed for an average of eight years. In that time, there were 198 strokes, 156 heart-related events and 586 deaths.  The group was comprised of 63 percent Hispanic, 20 percent non-Hispanic black and 15 percent non-Hispanic white residents.

The study's researchers found that people with CRP levels greater than three milligrams per liter were 70 percent more likely to suffer a heart attack and 55 percent more likely to die early compared to people who had levels of one milligram per liter or less of the protein in their blood. The protein was not associated with an increased risk of stroke once other risk factors were taken into account.

Prior studies have found the C-reactive protein to be a marker for predicting risk of heart disease.  CRP protein levels are associated with such medical and lifestyle risk factors as diabetes, smoking, alcohol consumption and physical activity.   A lead researcher noted that by living a healthy lifestyle, one may be able to lower these protein levels, thus lowering the risk of cardiac events and possibly early death.

The study was supported by the National Institutes of Health.  Reported by Jesse Slome, American Association for Critical Illness Insurance.

Tuesday, October 20, 2009

Breast Cancer Developing Earlier

Researchers noted that breast cancer may be developing in more women at younger ages.

The findings presented at the 2009 Breast Cancer Symposium, held last week in San Francisco, could potentially affect how women are screened for breast cancer.  

Reserachers reported that women with a high genetic risk of developing breast cancer are being diagnosed sooner than similar women in the past.  They note this may suggest that tumors are being found earlier in the younger generation. 

About 5 percent to 10 percent of breast cancer cases are thought to be connected to a genetic mutation that is also linked to ovarian cancer. Women with the mutations, known as BRCA1 or BRCA2, have an increased risk of developing breast tumors the scientists noted. Over a lifetime, 60 percent of these women will develop the disease, according to the American Cancer Society. By comparison, 12 percent of women in the general population will develop breast cancer. 

Women who have the genetic mutation are advised to be screened for breast cancer starting when they are 25.  The same they note is true for women whose mothers or aunts have the genetic mutation.  A Mammography and MRI are now recommended for these women.

Some 1.4 million Americans were diagnosed with cancer last year according to the American Association for Critical Illness Insurance.  About 26 percent of cases diagnosed in women are breast cancer.

 

In the new study, the researchers examined the medical records of women with the genetic mutation who took part in the University of Texas M.D. Anderson Cancer Center's clinical cancer genetics program.  The median age of diagnosis in the newer generation was 42, but 47 in the older women. The study authors report that this is worrisome because it could mean that the cancer is developing earlier.

 

The findings the researchers noted are concerning and could have implications on the screening and genetic counseling of these women.

Monday, October 19, 2009

Smoking Bans Reduce Heart Attack Occurrence

October 19, 2009.  Smoking bans are effective at reducing the risk of heart attacks and heart disease associated with exposure to secondhand smoke. 

A new report from the Institute of Medicine confirms that there is sufficient evidence that breathing secondhand smoke boosts nonsmokers' risk for heart problems.  The medical researchers added that indirect evidence indicating that even relatively brief exposures could lead to a heart attack is compelling. 

According to the American Association for Critical Illness Insurance, some 43 percent of nonsmoking children and 37 percent of nonsmoking adults are exposed to secondhand smoke in the United States. Experts report that roughly 126 million nonsmokers were still being exposed in 2000.

A 2006 report from the U.S. Surgeon General's office concluded that exposure to secondhand smoke causes heart disease and indicated that smoke-free policies are the most economical and effective way to reduce exposure. However, the effectiveness of smoking bans in reducing heart problems has continued to be a source of debate.

The Institute of Medicine researchers conducted a comprehensive review of published and unpublished data and testimony on the relationship between secondhand smoke and short-term and long-term heart problems. Eleven key studies that evaluated the effects of smoking bans on heart attack rates informed the committee's conclusions about the positive effects of smoke-free policies. The studies calculated that reductions in the incidence of heart attacks range from 6 percent to 47 percent.

The report was sponsored by the U.S. Centers for Disease Control and Prevention. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public.

Friday, October 16, 2009

Breast Tenderness Linked To Elevated Cancer Risk

October 16, 2009.   Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer.  This compared to women on the combination therapy who didn't experience such tenderness. 

Breat cancer is the most common cancer among women according to the American Association for Critical Illness Insurance.  Some 692,000 women were diagnosed with cancer last year; about 26 percent with breast cancer.

According to researchers at the David Geffen School of Medicine at UCLA they are not certain why breast tenderness indicates increased cancer risk among women on the combination therapy.

The researchers based their findings by examining data on more than 16,000 participants in the Women's Health Initiative estrogen-plus- progestin clinical trial.   They speculated that it may be because the hormone therapy is causing breast-tissue cells to multiply more rapidly, which causes breast tenderness and at the same time indicates increased cancer risk. 

The UCLA research, published in the Oct. 12 issue of the Archives of Internal Medicine, compared the daily use of oral conjugated equine estrogens (0.625 mg) plus medroxyprogesterone acetate (2.5 mg), or CEE+MPA, with the daily use of a placebo pill. 

Of the participants in the trial, over 8,500 took estrogen plus progestin and just over 8,100 were given placebos. Participants underwent mammography and clinical breast exams at the start of the trial and annually thereafter. Self-reported breast tenderness was assessed at the beginning of the trial and one year later, and invasive breast cancer over the next 5.6 years was confirmed by medical record review. 

Women on the combination therapy who did not have breast tenderness at the trial's inception were found to have a threefold greater risk of developing tenderness at the one-year mark, compared with participants who were assigned placebos (36.1 percent vs. 11.8 percent). Among the women who did report breast tenderness at the beginning, the risk at one-year was about 1.26 times that of their counterparts on placebos. 

Of the women who reported new-onset breast tenderness, 76.3 percent had been on the combination therapy.

Women in the combination therapy group who did not have breast tenderness at the outset but experienced new-onset tenderness at the first annual follow-up had a 48 percent higher risk of invasive breast cancer than their counterparts on combination therapy who did not have breast tenderness at the first-year follow-up.

Thursday, October 15, 2009

Green Tea May Curb Some Cancers

October 15, 2009.  Drinking green tea may lower your risk of developing certain blood cancers.

According to a study by Japanese researchers noted that it may take at least  5 cups a day to reduce the risk.

Drinking green tea has been associated with lower risk of dying and heart disease deaths, medical experts have reported.  The just-released study notes that drinking green tea may have a favorable effect "for particular cancers."

Researchers gathered information on the diets and green tea drinking habits of a large group of Japanese adults aged 40 to 79 years old.  They followed the group for development of blood and "lymph system" cancers. The lymph system is a major component of the body's immune system.

Some 40,000 men and women who participated in the study had no previous history of cancer.  During 9 years of follow up, 157 blood, bone marrow, and lymph system cancers developed in the study group.

The researchers found that the overall risk for blood cancers was 42 percent lower among study participants who drank 5 or more, versus 1 or fewer, cups of green tea daily.  Drinking 5 or more cups of green tea daily was also associated with 48 percent lower risk for lymph system cancers.

These associations held up in analyses that allowed for age, gender, education, smoking status and history, alcohol use, and fish and soybean consumption.  The report appears in the American Journal of Epidemiology, September 15, 2009. 

October 15, 2009.  Drinking green tea may lower your risk of developing certain blood cancers.

According to a study by Japanese researchers noted that it may take at least  5 cups a day to reduce the risk.


Drinking green tea has been associated with lower risk of dying and heart disease deaths, medical experts have reported.  The just-released study notes that drinking green tea may have a favorable effect "for particular cancers."


Researchers gathered information on the diets and green tea drinking habits of a large group of Japanese adults aged 40 to 79 years old.  They followed the group for development of blood and "lymph system" cancers. The lymph system is a major component of the body's immune system.


Some 40,000 men and women who participated in the study had no previous history of cancer.  During 9 years of follow up, 157 blood, bone marrow, and lymph system cancers developed in the study group.


The researchers found that the overall risk for blood cancers was 42 percent lower among study participants who drank 5 or more, versus 1 or fewer, cups of green tea daily.  Drinking 5 or more cups of green tea daily was also associated with 48 percent lower risk for lymph system cancers.


These associations held up in analyses that allowed for age, gender, education, smoking status and history, alcohol use, and fish and soybean consumption.  The report appears in the American Journal of Epidemiology, September 15, 2009.

Posted by Jesse Slome
American Association for Critical Illness Insurance

Wednesday, October 14, 2009

Aging Heart Can Be Prevented

Old age is a major risk factor for heart failure, a condition when the heart is unable to pump enough blood around to supply the oxygen the body needs.  Some 5.7 million Americans have heart failure, and nearly 10 out of every 1,000 people over age 65 suffer heart failure every year according to the American Association for Critical Illness Insurance.

 

Japanese researchers at Kyoto University Graduate School of Medicine in Kyoto described how they managed to suppress a variety of the P13K gene in a group of elderly mice.  The gene regulates the lifespan of cells and plays a role in the aging of tissues.

 

Prior studies found that the suppression of this gene extended the lifespan roundworm and kept the hearts of old fruit flies healthy.  The Japanese researchers reported that compared with another group of mice in which the gene was left intact, mice with the suppressed gene had improved cardiac function and fewer biological markers of aging.

 

The medical researchers noted that mice are considered a good surrogate for studies of human diseases and conditions.  Their body plan, physiology and genome share many features with humans they note. The findings were published in the journal Circulation.

Tuesday, October 13, 2009

Skin Cancer Can Be Inherited

Two new studies suggest that skin cancer can be inhereited.

One study found that having an identical twin with melanoma increased a person's own risk of developing the disease much more than having a fraternal twin with this type of skin cancer.  The other study revealed that having a parent or sibling with one of several different types of non-melanoma skin cancer increased risk as well. 

Having an identical twin with melanoma increased a person's own risk of the disease nearly 10-fold, while melanoma associated with having a non-identical twin with the disease was roughly doubled. 

Prior studies have suggested melanoma and other skin cancers run in families.  But medical experts note it has been difficult to separate the difference between the influence of genes and those caused by other environmental conditions.  Some 1.4 million Americans are diagnosed with cancer each year according to the American Association for Critical Illness Insurance. 

A study conducted by researchers at the University of Queensland in Australia looked at twin pairs in which at least one sibling had been diagnosed with melanoma.  After looking at hundreds of candidates, the researchers found that in four of the 27 identical twin pairs, both had melanoma, while three of the 98 fraternal twin pairs had both been diagnosed with the deadly skin cancer. 

In the second study conducted at the University of California Los Angeles, researchers looked at the Swedish Family-Cancer Database to gauge the risk for several types of skin cancer among siblings and children of people diagnosed with these diseases.

They found that people with a sibling or parent diagnosed with some types of skin cancer were more likely to develop skin cancers of various types, not just the ones their relatives had. When tumors occurred at parts of the body more likely to have been exposed to the sun (such as the face, compared to the torso), the familial risk was stronger.  The findings were reported in the Journal of Investigative Dermatology, September 2009.

Monday, October 12, 2009

Reserachers Find New Way To Repair Heart Tissue

Bioengineers at Duke University believe they have found a way to grow a living heart patch that will aid in the repair of heart tissue damaged by disease.

Researchers announced they mimicked the way embryonic stem cells develop into heart muscle in a lab. Using mouse embryonic stem cells, the bioengineers used a novel mold of their own design to fashion a three-dimensional "patch" made up of heart muscle cells.

The new tissue exhibited the two most important attributes of heart muscle cells -– the ability to contract and to conduct electrical impulses. The researchers grew the cells in an environment much like that found in natural tissues.

The scientists reported that they were able to grow heart muscle cells that were able to contract with strength and carry electric impulses quickly.  One of the major challenges they still face is establishing a blood vessel supply to sustain the patch.

The researchers plan to test their model using non-embryonic stem cells.  Recent studies have demonstrated that some cells from human adults have the ability to be reprogrammed to become similar to embryonic stem cells.

Posted by Jesse Slome
American Association for Critical Illness Insurance

To read more about critical illness insurance visit the organization's qwebsite where you can obtain a no-obligation cost quote from an Association member.

Sunday, October 11, 2009

Women With Breast Cancer Have Low Vitamin D Levels

October 11, 2009.   Women with breast cancer are likely to have low levels of vitamin D, which could contribute to decreased bone mass and greater risk of fractures.

The finding comes from scientists at the University of Rochester Medical Center who recommend women should be given high doses of vitamin D. The U.S. Institute of Medicine suggests that blood levels nearing 32 nanograms per milliliter are adequate.

Vitamin D, obtained from milk, fortified cereals and exposure to sunlight, is well known to play an essential role in cell growth, in boosting the body's immune system and in strengthening bones. In a study of women undergoing treatment for breast cancer, nearly 70 percent had low levels of vitamin D in their blood, according to a study presented at the American Society of Clinical Oncology's Breast Cancer Symposium in San Francisco.

The analysis showed women with late-stage disease and non-Caucasian women had even lower levels. Scientists analyzed vitamin D levels in each woman. They found the average level was 27 nanograms per milliliter. More than two-thirds of the women had vitamin deficiency.

Weekly supplementation with high doses of vitamin D -- 50,000 international units or more -- improved the levels, according to the researchers. Previous studies have shown that nearly half of all men and women are deficient in the nutrient, with vitamin D levels below 32 nanograms per milliliter. Symptoms of Vitamin D deficiency include muscle pain, low energy and fatigue, lowered immunity, symptoms of depression and sleep irregularities.

Some 692,000 American women are diagnosed annually with cancer in the United States according to the American Association for Critical Illness Insurance, the national trade group. Breast cancer is the most common cancer affecting 26 percent of women diagnosed with the illness.

Saturday, October 10, 2009

Shingles Raises Risk Of Stroke In Adults

Adults with shingles were about 30 percent more likely to have a stroke during a one-year follow-up than adults without shingles.

According to a study published in Stroke: Journal of the American Heart Association the risk was even greater when the infection involved the eyes.  Every 40 seconds someone in America has a stroke, according to the American Association for Critical Illness Insurance.  Stroke is the leading cause of serious, long-term disability in the United States.

Shingles, also called herpes zoster, is a painful skin rash caused by the varicella zoster virus; the same virus that causes chickenpox. After a person recovers from chickenpox, the virus stays in the body. Usually the virus doesn’t cause problems, but it can reappear years later, causing shingles. 

Studies have shown that people with herpes zoster infection are more likely to develop stroke. The researchers noted that this is the first study to demonstrate the actual risk of stroke following herpes zoster infection.

Medical experts at the Taipei Medical University Hospital studied some 8,000 patients 18 years and older who received shingles treatment between 1997 and 2001. These people were matched by age and gender with 23,280 adults who weren’t treated for shingles (controls). 

During the one-year follow-up, 133 shingles patients (about 1.7 percent) and 306 of the controls (about 1.3 percent) had strokes.   The researchers noted that people treated for a shingles infection were 31 percent more likely to have a stroke, compared with patients without a shingles infection.

Patients with shingles infections that involved the skin around the eye and the eye itself were 4.28 times more likely to have a stroke than patients without shingles.  Shingles patients were 31 percent more likely to develop an ischemic stroke during the one-year follow-up than those without shingles. 

Ischemic strokes, which are caused by the blockage of an artery, account for 87 percent of the new or recurrent strokes that strike some 800,000 Americans yearly, Jesse Slome, executive director of the critical illness insurance trade group. 

Shingles usually starts as a rash on one side of the face or body. The rash starts as blisters that scab after three to five days and usually clears within two to four weeks. There is often pain, itching or tingling in the area where the rash develops.